Adult respiratory outcomes of extreme preterm birth a regional cohort study

Annals of the American Thoracic Society

Volumn 12, Issue 3, 2015, Pages 313-322

  Vollsæter, Maria ^a,b   Clemm, Hege H ^a,b   Satrell, Emma ^a   Eide, Geir E ^a,b   Røksund, Ola D ^b,c   Markestad, Trond ^a,b   Halvorsen, Thomas ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c BERGEN UNIVERSITY COLLEGE   (Norway)

Author keywords

Bronchopulmonary dysplasia; Chronic obstructive pulmonary disease; Premature birth

Indexed keywords

HEMOGLOBIN; METHACHOLINE;

ADULT; AIRWAY RESISTANCE; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; INTERVIEW; LUNG DYSPLASIA; LUNG FUNCTION; MALE; NORWAY; OUTCOME ASSESSMENT; PREMATURE LABOR; RESIDUAL VOLUME; SPIROMETRY; TOTAL LUNG CAPACITY;

EID: 84964273552     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201406-285OC     Document Type: Article

References (54)

1. Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, Adler A, Vera Garcia C, Rohde S, Say L, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 2012;379:2162-2172.
2. Markestad T, Kaaresen PI, Ronnestad A, Reigstad H, Lossius K, Medbo S, Zanussi G, Engelund IE, Skjaerven R, Irgens LM; Norwegian Extreme Prematurity Study Group. Early death, morbidity, and need of treatment among extremely premature infants. Pediatrics 2005;115:1289-1298.
3. Stoelhorst GM, Rijken M, Martens SE, Brand R, Den Ouden AL, Wit JM, Veen S; Leiden Follow-Up Project on Prematurity. Changes in neonatology: comparison of two cohorts of very preterm infants (gestational age, 32 weeks): the Project on Preterm and Small for Gestational Age Infants 1983 and the Leiden Follow-Up Project on Prematurity 1996-1997. Pediatrics 2005;115:396-405.
4. Moster D, Lie RT, Markestad T. Long-term medical and social consequences of preterm birth. N Engl J Med 2008;359:262-273.
5. Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med 2007;357:1946-1955.
6. Kotecha SJ, Edwards MO, Watkins WJ, Henderson AJ, Paranjothy S, Dunstan FD, Kotecha S. Effect of preterm birth on later FEV1: a systematic review and meta-analysis. Thorax 2013;68:760-766.
7. Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease: bronchopulmonary dysplasia. N Engl J Med 1967;276:357-368.
8. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723-1729.
9. Kobaly K, Schluchter M, Minich N, Friedman H, Taylor HG, Wilson-Costello D, Hack M. Outcomes of extremely low birth weight (, 1 kg) and extremely low gestational age (, 28 weeks) infants with bronchopulmonary dysplasia: effects of practice changes in 2000 to 2003. Pediatrics 2008;121:73-81.
10. Doyle LW; Victorian Infant Collaborative Study Group. Respiratory function at age 8-9 years in extremely low birthweight/very preterm children born in Victoria in 1991-1992. Pediatr Pulmonol 2006;41:570-576.
11. Fawke J, Lum S, Kirkby J, Hennessy E, Marlow N, Rowell V, Thomas S, Stocks J. Lung function and respiratory symptoms at 11 years in children born extremely preterm: the EPICure study. Am J Respir Crit Care Med 2010;182:237-245.
12. Filippone M, Bonetto G, Cherubin E, Carraro S, Baraldi E. Childhood course of lung function in survivors of bronchopulmonary dysplasia. JAMA 2009;302:1418-1420.
13. Narang I, Rosenthal M, Cremonesini D, Silverman M, Bush A. Longitudinal evaluation of airway function 21 years after preterm birth. Am J Respir Crit Care Med 2008;178:74-80.
14. Doyle LW, Faber B, Callanan C, Freezer N, Ford GW, Davis NM. Bronchopulmonary dysplasia in very low birth weight subjects and lung function in late adolescence. Pediatrics 2006;118:108-113.
15. Chambers DC. Lung function in ex preterm adults. Am J Respir Crit Care Med 2009;2009:15.
16. Vollsaeter M, Roksund OD, Eide GE, Markestad T, Halvorsen T. Lung function after preterm birth: development from mid-childhood to adulthood. Thorax 2013;68:767-776.
17. Trachsel D, Brutsche MH, Hug-Batschelet H, Hammer J. Progressive static pulmonary hyperinflation in survivors of severe bronchopulmonary dysplasia by mid-adulthood. Thorax 2012;67:747-748.
18. Kalhan R, Arynchyn A, Colangelo LA, Dransfield MT, Gerald LB, Smith LJ. Lung function in young adults predicts airflow obstruction 20 years later. Am J Med 2010;123:468.e1-e7.
19. Halvorsen T, Skadberg BT, Eide GE, Roksund OD, Carlsen KH, Bakke P. Pulmonary outcome in adolescents of extreme preterm birth: a regional cohort study. Acta Paediatr 2004;93:1294-1300.
20. Halvorsen T, Skadberg BT, Eide GE, Roksund O, Aksnes L, Oymar K. Characteristics of asthma and airway hyper-responsiveness after premature birth. Pediatr Allergy Immunol 2005;16:487-494.
21. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998;351:1225-1232.
22. American Thoracic Society/European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005;171:912-930.
23. O'Connor G, Sparrow D, Taylor D, Segal M, Weiss S. Analysis of dose-response curves to methacholine: an approach suitable for population studies. Am Rev Respir Dis 1987;136:1412-1417.
24. Jayet PY, Schindler C, Kunzli N, Zellweger JP, Brandli O, Perruchoud AP, et al. Reference values for methacholine reactivity (SAPALDIA study). Respir Res 2005;6:131.
25. Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, et al.; American Thoracic Society/European Respiratory Society Task Force on Asthma Control and Exacerbations. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009;180:59-99.
26. Clemm H, Roksund O, Thorsen E, Eide GE, Markestad T, Halvorsen T. Aerobic capacity and exercise performance in young people born extremely preterm. Pediatrics 2012;129:e97-e105.
27. Remes ST, Pekkanen J, Remes K, Salonen RO, Korppi M. In search of childhood asthma: questionnaire, tests of bronchial hyperresponsiveness, and clinical evaluation. Thorax 2002;57:120-126.
28. Davis C. Statistical Methods for the analysis of repeated measures. Heidelberg, Germany: Springer Verlag; 2002.
29. Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, Enright PL, Hankinson JL, Ip MS, Zheng J, et al.; ERS Global Lung Function Initiative. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J 2012;40:1324-1343.
30. Stocks J, Quanjer PH. Reference values for residual volume, functional residual capacity and total lung capacity: ATS Workshop on Lung Volume Measurements. Official statement of the European Respiratory Society. Eur Respir J 1995;8:492-506.
31. Walsh MC, Wilson-Costello D, Zadell A, Newman N, Fanaroff A. Safety, reliability, and validity of a physiologic definition of bronchopulmonary dysplasia. J Perinatol 2003;23:451-456.
32. Bolton CE, Bush A, Hurst JR, Kotecha S, McGarvey L, Stocks J, Walshaw MJ. Are early life factors considered when managing respiratory disease? A British Thoracic Society survey of current practice. Thorax 2012;67:1110.
33. Hacking DF, Gibson AM, Robertson C, Doyle LW. Respiratory function at age 8-9 after extremely low birthweight or preterm birth in Victoria in 1997. Pediatr Pulmonol 2013;48:449-455.
34. Wong PM, Lees AN, Louw J, Lee FY, French N, Gain K, Murray CP, Wilson A, Chambers DC. Emphysema in young adult survivors of moderate-to-severe bronchopulmonary dysplasia. Eur Respir J 2008;32:321-328.
35. Gough A, Linden M, Spence D, Patterson CC, Halliday HL, McGarvey LP. Impaired lung function and health status in adult survivors of bronchopulmonary dysplasia. Eur Respir J 2013;68:760-766.
36. Northway WH Jr, Moss RB, Carlisle KB, Parker BR, Popp RL, Pitlick PT, Eichler I, Lamm RL, Brown BW Jr. Late pulmonary sequelae of bronchopulmonary dysplasia. N Engl J Med 1990;323:1793-1799.
37. Ulrik CS. Factors associated with increased bronchial responsiveness in adolescents and young adults: the importance of adjustment for prechallenge FEV1. J Allergy Clin Immunol 1996;97:761-767.
38. Rijcken B, Schouten JP, Xu X, Rosner B, Weiss ST. Airway hyperresponsiveness to histamine associated with accelerated decline in FEV1. Am J Respir Crit Care Med 1995;151:1377-1382.
39. Marcon A, Cerveri I, Wjst M, Anto J, Heinrich J, Janson C, et al. Can an airway challenge test predict respiratory diseases? A populationbased international study. J Allergy Clin Immunol 2014;133:104-110. e1-4.
40. Lum S, Kirkby J, Welsh L, Marlow N, Hennessy E, Stocks J. Nature and severity of lung function abnormalities in extremely pre-term children at 11 years of age. Eur Respir J 2011;37:1199-1207.
41. Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, MacIntyre NR, McKay RT, Wanger JS, Anderson SD, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000;161:309-329.
42. Vrijlandt EJ, Gerritsen J, Boezen HM, Grevink RG, Duiverman EJ. Lung function and exercise capacity in young adults born prematurely. Am J Respir Crit Care Med 2006;173:890-896.
43. Filippone M, Carraro S, Baraldi E. The term "asthma" should be avoided in describing the chronic pulmonary disease of prematurity. Eur Respir J 2013;42:1430-1431.
44. Pantalitschka T, Poets CF. Inhaled drugs for the prevention and treatment of bronchopulmonary dysplasia. Pediatr Pulmonol 2006;41:703-708.
45. Filippone M, Bonetto G, Corradi M, Frigo AC, Baraldi E. Evidence of unexpected oxidative stress in airways of adolescents born very pre-term. Eur Respir J 2012;40:1253-1259.
46. Coalson JJ. Pathology of bronchopulmonary dysplasia. Semin Perinatol 2006;30:179-184.
47. Brusasco V, Pellegrino R. Complexity of factors modulating airway narrowing in vivo: relevance to assessment of airway hyperresponsiveness. J Appl Physiol (1985) 2003;95:1305-1313.
48. Bellofiore S, Eidelman DH, Macklem PT, Martin JG. Effects of elastaseinduced emphysema on airway responsiveness to methacholine in rats. J Appl Physiol (1985) 1989;66:606-612.
49. Narayanan M, Beardsmore CS, Owers-Bradley J, Dogaru CM, Mada M, Ball I, Garipov RR, Kuehni CE, Spycher BD, Silverman M. Catch-up alveolarization in ex-preterm children: evidence from (3) He magnetic resonance. Am J Respir Crit Care Med 2013;187:1104-1109.
50. Eber E. Paediatric origins of adult lung disease bullet 8: long term sequelae of bronchopulmonary dysplasia (chronic lung disease of infancy). Thorax 2001;56:317-323.
51. Wohl ME. Bronchopulmonary dysplasia in adulthood. N Engl J Med 1990;323:1834-1836.
52. Parker DR, O'Connor GT, Sparrow D, Segal MR, Weiss ST. The relationship of nonspecific airway responsiveness and atopy to the rate of decline of lung function: the Normative Aging Study. Am Rev Respir Dis 1990;141:589-594.
53. Svanes C, Sunyer J, Plana E, Dharmage S, Heinrich J, Jarvis D, De Marco R, Norbäck D, Raherison C, Villani S, et al. Early life origins of chronic obstructive pulmonary disease. Thorax 2009;65:14-20.
54. Carraro S, Scheltema N, Bont L, Baraldi E. Early-life origins of chronic respiratory diseases: understanding and promoting healthy ageing. Eur Respir J 2014;44:1682-1696.